These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 26758691

  • 21. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.
    Zabaleta N, Barberia M, Martin-Higueras C, Zapata-Linares N, Betancor I, Rodriguez S, Martinez-Turrillas R, Torella L, Vales A, Olagüe C, Vilas-Zornoza A, Castro-Labrador L, Lara-Astiaso D, Prosper F, Salido E, Gonzalez-Aseguinolaza G, Rodriguez-Madoz JR.
    Nat Commun; 2018 Dec 21; 9(1):5454. PubMed ID: 30575740
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Primary hyperoxaluria type 1: novel therapies at a glance.
    Bacchetta J, Lieske JC.
    Clin Kidney J; 2022 May 21; 15(Suppl 1):i17-i22. PubMed ID: 35592618
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hepatic alanine-glyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats.
    Nishijima S, Sugaya K, Morozumi M, Hatano T, Ogawa Y.
    J Urol; 2003 Feb 21; 169(2):683-6. PubMed ID: 12544342
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficient and safe in vivo treatment of primary hyperoxaluria type 1 via LNP-CRISPR-Cas9-mediated glycolate oxidase disruption.
    Jiang Y, Chen S, Hsiao S, Zhang H, Xie D, Wang ZJ, Ren W, Liu M, Liao J, Wu Y.
    Mol Ther; 2024 Oct 09. PubMed ID: 39385468
    [Abstract] [Full Text] [Related]

  • 32. Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
    Castello R, Borzone R, D'Aria S, Annunziata P, Piccolo P, Brunetti-Pierri N.
    Gene Ther; 2016 Feb 09; 23(2):129-34. PubMed ID: 26609667
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y, Parnham AP, Falk MC, Burke JR, Nicol D, Yamanaka J, Lynch SV, Strong RW.
    Clin Transplant; 1997 Oct 09; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [Abstract] [Full Text] [Related]

  • 35. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS, Groothof JW, Wanders RJ, Waterham HR, Wijburg FR.
    Ned Tijdschr Geneeskd; 2006 Jul 29; 150(30):1669-72. PubMed ID: 16922352
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Molecular aetiology of primary hyperoxaluria type 1.
    Danpure CJ.
    Nephron Exp Nephrol; 2004 Jul 29; 98(2):e39-44. PubMed ID: 15499210
    [Abstract] [Full Text] [Related]

  • 38. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
    Zheng R, Fang X, He L, Shao Y, Guo N, Wang L, Liu M, Li D, Geng H.
    Curr Mol Med; 2018 Jul 29; 18(7):436-447. PubMed ID: 30539697
    [Abstract] [Full Text] [Related]

  • 39. Glycolate and glyoxylate metabolism in HepG2 cells.
    Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP.
    Am J Physiol Cell Physiol; 2004 Nov 29; 287(5):C1359-65. PubMed ID: 15240345
    [Abstract] [Full Text] [Related]

  • 40. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
    Garrelfs SF, van Harskamp D, Peters-Sengers H, van den Akker CHP, Wanders RJA, Wijburg FA, van Goudoever JB, Groothoff JW, Schierbeek H, Oosterveld MJS.
    J Am Soc Nephrol; 2021 Dec 01; 32(12):3175-3186. PubMed ID: 34686543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.